Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/bjc2012605.pdf
Reference50 articles.
1. Barbet J, Bardies M, Bourgeois M, Chatal J-F, Cherel M, Davodeau F, Faivre-Chauvet A, Gestin J-F, Kraeber-Bodere F (2012) Radiolabeled antibodies for cancer imaging and therapy. Methods Mol Biol 907: 681–697
2. Bhargava R, Chen B, Klimstra DS, Saltz LB, Hedvat C, Tang LH, Gerald W, Teruya-Feldstein J, Paty PB, Qin J, Shia J (2006) Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa. Cancer 106 (8): 1857–1862
3. Boerman OC, Oyen WJG (2011) Immuno-PET of cancer: a revival of antibody imaging. J Nucl Med 52 (8): 1171–1172
4. Buckley AF, Kakar S (2007) Comparison of the dako EGFR pharmDx kit and zymed EGFR antibody for assessment of EGFR status in colorectal adenocarcinoma. Appl Immunohistochem 15 (3): 305–309
5. Camp RL, Charette LA, Rimm DL (2000) Validation of tissue microarray technology in breast carcinoma. Lab Invest 80 (12): 1943–1949
Cited by 128 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tumour Marker Expression in Head and Neck Malignancies to Identify Potential Targets for Intraoperative Molecular Near-Infrared Imaging;Molecular Diagnosis & Therapy;2024-09-09
2. A Concept for Preoperative and Intraoperative Molecular Imaging and Detection for Assessing Extent of Disease of Solid Tumors;Oncology Reviews;2024-07-25
3. Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer;International Journal of Nanomedicine;2024-07
4. CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials;Nature Communications;2024-05-15
5. Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer;Molecular Cancer Therapeutics;2024-04-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3